AP730A - Gene expression in mammalian cells. - Google Patents

Gene expression in mammalian cells. Download PDF

Info

Publication number
AP730A
AP730A APAP/P/1997/001091A AP9701091A AP730A AP 730 A AP730 A AP 730A AP 9701091 A AP9701091 A AP 9701091A AP 730 A AP730 A AP 730A
Authority
AP
ARIPO
Prior art keywords
cells
promoter
interferon
human
gene
Prior art date
Application number
APAP/P/1997/001091A
Other languages
English (en)
Other versions
AP9701091A0 (en
Inventor
Yin Hwee Tan
Wanjin Hong
Original Assignee
Inst Of Molecular And Cell Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Of Molecular And Cell Biology filed Critical Inst Of Molecular And Cell Biology
Publication of AP9701091A0 publication Critical patent/AP9701091A0/xx
Application granted granted Critical
Publication of AP730A publication Critical patent/AP730A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
APAP/P/1997/001091A 1995-03-24 1996-03-22 Gene expression in mammalian cells. AP730A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9506051.3A GB9506051D0 (en) 1995-03-24 1995-03-24 Gene expression
PCT/CA1996/000174 WO1996030531A1 (en) 1995-03-24 1996-03-22 Gene expression in mammalian cells

Publications (2)

Publication Number Publication Date
AP9701091A0 AP9701091A0 (en) 1997-10-31
AP730A true AP730A (en) 1999-02-04

Family

ID=10771834

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1997/001091A AP730A (en) 1995-03-24 1996-03-22 Gene expression in mammalian cells.

Country Status (16)

Country Link
US (1) US6207146B1 (hu)
EP (1) EP0815251A1 (hu)
JP (1) JPH11502705A (hu)
KR (1) KR19980703275A (hu)
CN (1) CN1185180A (hu)
AP (1) AP730A (hu)
AU (1) AU722341B2 (hu)
BR (1) BR9607831A (hu)
CA (1) CA2216174A1 (hu)
GB (2) GB9506051D0 (hu)
HK (1) HK1005248A1 (hu)
HU (1) HUP9800520A3 (hu)
IL (1) IL117594A (hu)
NO (1) NO974367L (hu)
NZ (1) NZ303133A (hu)
WO (1) WO1996030531A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002310922A1 (en) * 2001-05-04 2002-11-18 Institute Of Molecular And Cell Biology Interferons in the treatment of ischemia
FR2843973B1 (fr) * 2002-08-30 2006-07-07 Agronomique Inst Nat Rech Cassettes d'expression procaryotes regulees par le zinc
GB0524782D0 (en) * 2005-12-05 2006-01-11 Chiron Srl Analysis of samples
CN100432230C (zh) * 2006-05-11 2008-11-12 南京大学 一种金属硫蛋白融合表达方法及其应用
AU2008317354B2 (en) * 2007-10-25 2014-04-10 Ospedale San Raffaele S.R.L. Methods and compositions for targeted integration
EP3768846B1 (en) * 2018-03-21 2023-06-21 Aldevron, L.L.C. Viral and non-viral nanoplasmid vectors with improved production

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0270799A1 (en) * 1986-10-27 1988-06-15 Cetus Oncology Corporation Pharmaceutical compositions of recombinant beta-interferon and formulation processes
EP0529300A1 (de) * 1991-08-27 1993-03-03 Dr. Rentschler Biotechnologie GmbH Neues rekombinantes Human-IFN-beta, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zubereitungen
EP0551535A1 (en) * 1992-01-13 1993-07-21 SCLAVO S.p.A. Process for the purification of recombinant human beta interferon, beta interferon thus purified, and pharmaceutical compositions which contain them

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514567A (en) 1979-01-30 1996-05-07 Juridical Foundation, Japanese Foundation For Cancer Research DNA and recombinant plasmid
AU538665B2 (en) 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
US4966843A (en) 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
DE3688418T2 (de) * 1985-02-13 1993-08-26 Scios Nova Inc Menschlicher metallothionein ii-promotor in saeugetierexpressionssystemen.
GB2177914B (en) * 1985-06-04 1989-10-25 Chugai Pharmaceutical Co Ltd A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia
US4954437A (en) * 1986-09-15 1990-09-04 Integrated Genetics, Inc. Cell encoding recombinant human erythropoietin
DE3712564A1 (de) 1987-04-14 1988-11-24 Bioferon Biochem Substanz Verfahren zur konstruktion einer animalen zellinie fuer die herstellung von humanem interferon-beta
DD287531A5 (de) 1988-06-16 1991-02-28 Akademie Der Wissenschaften,De Verfahren zur herstellung von humanem wachstumshormon (sth) in tierischen zellen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0270799A1 (en) * 1986-10-27 1988-06-15 Cetus Oncology Corporation Pharmaceutical compositions of recombinant beta-interferon and formulation processes
EP0529300A1 (de) * 1991-08-27 1993-03-03 Dr. Rentschler Biotechnologie GmbH Neues rekombinantes Human-IFN-beta, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zubereitungen
EP0551535A1 (en) * 1992-01-13 1993-07-21 SCLAVO S.p.A. Process for the purification of recombinant human beta interferon, beta interferon thus purified, and pharmaceutical compositions which contain them

Also Published As

Publication number Publication date
GB9720467D0 (en) 1997-11-26
GB2314332A (en) 1997-12-24
GB2314332B (en) 1999-06-30
KR19980703275A (ko) 1998-10-15
IL117594A0 (en) 1996-07-23
HK1005248A1 (en) 1998-12-31
NO974367D0 (no) 1997-09-22
WO1996030531A1 (en) 1996-10-03
CN1185180A (zh) 1998-06-17
GB9506051D0 (en) 1995-05-10
BR9607831A (pt) 1999-11-30
NZ303133A (en) 1999-11-29
CA2216174A1 (en) 1996-10-03
AU4935896A (en) 1996-10-16
AP9701091A0 (en) 1997-10-31
HUP9800520A3 (en) 1999-09-28
IL117594A (en) 2002-11-10
JPH11502705A (ja) 1999-03-09
HUP9800520A2 (hu) 1998-06-29
US6207146B1 (en) 2001-03-27
AU722341B2 (en) 2000-07-27
NO974367L (no) 1997-11-24
EP0815251A1 (en) 1998-01-07
MX9707244A (es) 1998-08-30

Similar Documents

Publication Publication Date Title
US4703008A (en) DNA sequences encoding erythropoietin
EP0668351B1 (en) Erythropoietin analogs
US5547933A (en) Production of erythropoietin
CA1339047C (en) Production of erythropoietin
KR100361997B1 (ko) 안정한살균/투과성-증가단백질산물및그것을포함하는제약학적조성물
EP1809661B1 (en) Human interferon-beta mutein
US20080108560A1 (en) Heterologous G-Csf Fusion Proteins
EP2292650A1 (en) Methods and compositions for the prevention and treatment of anemia
US7098318B2 (en) Fusion protein having enhanced in vivo activity of erythropoietin
AU606585B2 (en) Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
US5545536A (en) Colony-stimulating factor derivatives
AP730A (en) Gene expression in mammalian cells.
US20040254351A1 (en) Hyperglycosylated polypeptides
MXPA97007244A (en) Expression of genes in mamif cells
CA1339207C (en) The generation of recombinant eukaryotic cells with high-level expression
JP2798659B2 (ja) ヒトアンチトロンビンｉｉｉ（ａｔｉｉｉ）の製造
RU2261276C2 (ru) Выделенная молекула днк, кодирующая эритропоэтин человека, (варианты), экспрессирующий плазмидный или вирусный днк-вектор, гликопротеид эритропоэтин (варианты) и способ его получения, фармацевтическая композиция (варианты), линия клеток млекопитающего (варианты)
KR100512018B1 (ko) 상동 재조합에 의해 인간 세포에서 인간 변이 단백질을 생성시키는 방법
AU4252400A (en) Production of erythropoietin
AU1974001A (en) Production of erythropoietin
SK443885A3 (en) Dna sequence, a plasmid, vector, host cell, polypeptide of an erythropoietin-type, method of its production and pharmaceutical composition based thereon